Henan Taloph Pharmaceutical Stock Co.,Ltd. Posted 42.8 Million Yuan Net Loss in First Half of 2023

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net loss of 42.8 million yuan in the first half of 2023, widening 77.2% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 15.1% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 57.1%.